Background Accurate quantitative measurements of central corneal thickness (CCT) provide valuable, clinical information for preoperative assessment, surgical planning, and follow-up in myopic patients who have undergone LASIK correction. Typically, an ultrasound is used to measure such parameters. However, noncontact devices such as the Visante anterior segment optical coherence tomographer [AS-optical coherence tomography (OCT)] and Pentacam are becoming more popular to measure ocular parameters. It is important to assess the level of similarity between these two optical devices to compare between the intended and achieved ablation depth after LASIK procedures in cases of myopia and myopic astigmatism. Methods This cross-sectional, prospective study included 80 eyes of 40 patients attending Beni-Suef University Hospital between November 2018 and November 2019. All patients underwent LASIK surgery for the correction of myopia with or without myopic astigmatism with spherical equivalent ranging from − 1.5 to − 12 diopters. Results No statistically significant difference was observed between the intended ablation depth and the clinically measured ablation depth calculated by Pentacam and AS-OCT 3 months after surgery (P > 0.05). Conclusion When planning corneal refraction surgery, ablation depth readouts calculated by the computer software of the excimer laser used in this study are reliable. Both Pentacam and AS-OCT are accurate, sensitive, and specific in measuring the CCT and calculating ablation depth. Pentacam provides slightly higher accuracy and sensitivity compared with AS-OCT. LASIK is a safe, predictable, and effective procedure in the treatment of simple myopia and myopic astigmatism.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.